Disseminated superficial actinic porokeratosis: A treatment review

References

• K Wolff LG, Katz SI, Gilchrest B, Paller AS, Leffel DJ. Porokeratosis. In: Grainne M, O'Regan ADI, editors. Fitzpatrick's dermatology in general medicine. 7th ed. 1999.
   Google Scholar
• Chernosky ME, Freeman RG. Disseminated superficial actinic porokeratosis (DSAP). Arch Dermatol. 1967;96:611–624.
   PubMedGoogle Scholar
• Xia JH, Yang YF, Deng H, Tang BS, Tang DS, He YG, Identification of a locus for disseminated superficial actinic porokeratosis at chromosome 12q23.2-24.1. J Invest Dermatol. 2000;114:1071–1074.
   Google Scholar
• Xia K, Deng H, Xia JH, Zheng D, Zhang HL, Lu CY, A novel locus (DSAP2) for disseminated superficial actinic porokeratosis maps to chromosome 15q25.1-26.1. Br J Dermatol. 2002;147:650–654.
   Google Scholar
• Reed RJ, Leone P. Porokeratosis – a mutant clonal keratosis of the epidermis. I. Histogenesis. Arch Dermatol. 1970;101:340–347.
   PubMedGoogle Scholar
• Otsuka F, Shima A, Ishibashi Y. Porokeratosis has neoplastic clones in the epidermis: Microfluorometric analysis of DNA content of epidermal cell nuclei. J Invest Dermatol. 1989;92:231S–233S.
   Google Scholar
• Bencini PL, Tarantino A, Grimalt R, Ponticelli C, Caputo R. Porokeratosis and immunosuppression. Br J Dermatol. 1995;132:74–78.
   Google Scholar
• Maubec E, Duvillard P, Margulis A, Bachollet B, Degois G, Avril MF. Common skin cancers in porokeratosis. Br J Dermatol. 2005;152:1389–1391.
   PubMed Web of Science ®Google Scholar
• Topical diclofenac: new preparation. Moderate efficacy in actinic keratosis. Prescrire Int. 2004;13:138–139.
   Google Scholar
• Vlachou C, Kanelleas AI, Martin-Clavijo A, Berth-Jones J. Treatment of disseminated superficial actinic porokeratosis with topical diclofenac gel: A case series. J Eur Acad Dermatol Venereol. 2008;22:1343–1345.
   PubMed Web of Science ®Google Scholar
• Marks S, Varma R, Cantrell W, Chen SC, Gold M, Muellenhoff M, Diclofenac sodium 3% gel as a potential treatment for disseminated superficial actinic porokeratosis. J Eur Acad Dermatol Venereol. 2009;23:42–45.
   PubMed Web of Science ®Google Scholar
• Babilas P, Karrer S, Sidoroff A, Landthaler M, Szeimies RM. Photodynamic therapy in dermatology – An update. Photodermatol Photoimmunol Photomed. 2005;21:142–149.
   PubMedGoogle Scholar
• Morton CA, Brown SB, Collins S, Ibbotson S, Jenkinson H, Kurwa H, Guidelines for topical photodynamic therapy: Report of a workshop of the British Photodermatology Group. Br J Dermatol. 2002;146:552–567.
   PubMed Web of Science ®Google Scholar
• Soler AM, Warloe T, Berner A, Giercksky KE. A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolaevulinate-based photodynamic therapy alone and with prior curettage. Br J Dermatol. 2001;145:467–471.
   PubMed Web of Science ®Google Scholar
• Nayeemuddin FA, Wong M, Yell J, Rhodes LE. Topical photodynamic therapy in disseminated superficial actinic porokeratosis. Clin Exp Dermatol. 2002;27:703–706.
   PubMed Web of Science ®Google Scholar
• Baptista J, Martinez C, Leite L, Cochito M. Our PDT experience in the treatment of non-melanoma skin cancer over the last 7 years. J Eur Acad Dermatol Venereol. 2006;20:693–697.
   Google Scholar
• Cavicchini S, Tourlaki A. Successful treatment of disseminated superficial actinic porokeratosis with methyl aminolevulinate-photodynamic therapy. J Dermatolog Treat. 2006;17:190–191.
   Web of Science ®Google Scholar
• Fernandez-Guarino M, Harto A, Perez-Garcia B, Martin-Gonzalez M, Urrutia S, Jaen P. Photodynamic therapy in disseminated superficial actinic porokeratosis. J Eur Acad Dermatol Venereol. 2009;23:176–177.
   PubMed Web of Science ®Google Scholar
• Taub AF. Photodynamic therapy: Other uses. Dermatol Clin. 2007;25:101–109.
   Google Scholar
• Harrison PV, Stollery N. Disseminated superficial actinic porokeratosis responding to calcipotriol. Clin Exp Dermatol. 1994;19:95.
   PubMed Web of Science ®Google Scholar
• Bohm M, Luger TA, Bonsmann G. Disseminated superficial actinic porokeratosis: Treatment with topical tacalcitol. J Am Acad Dermatol. 1999;40:479–480.
   PubMed Web of Science ®Google Scholar
• Niimi Y, Kawana S. Type 2 segmental manifestation of disseminated superficial actinic porokeratosis in a 7-year-old girl. Eur J Dermatol. 2009;19:25–28.
   Google Scholar
• Shelley WB, Shelley ED. Disseminated superficial porokeratosis: Rapid therapeutic response to 5-fluorouracil. Cutis. 1983;32:139–140.
   PubMed Web of Science ®Google Scholar
• Nahm WK, Donohue KG, Danahy JF, Badiavas E, Falanga V. Systemic 5-fluorouracil producing an inflammatory response in porokeratosis. J Eur Acad Dermatol Venereol. 2003;17:190–192.
   Google Scholar
• Epstein E. Does intermittent ‘pulse’ topical 5-fluorouracil therapy allow destruction of actinic keratoses without significant inflammation? J Am Acad Dermatol. 1998;38:77–80.
   PubMed Web of Science ®Google Scholar
• Teixeira SP, de Nascimento MM, Bagatin E, Hassun KM, Talarico S, Michalany N. The use of fluor-hydroxy pulse peel in actinic porokeratosis. Dermatol Surg. 2005;31:1145–1148.
   PubMedGoogle Scholar
• Kariniemi AL, Stubb S, Lassus A. Treatment of disseminated superficial actinic porokeratosis with a new aromatic retinoid (Ro 10-9359). Br J Dermatol. 1980;102:213–214.
   Google Scholar
• Carmichael AJ, Tan CY. Digitate keratoses – A complication of etretinate used in the treatment of disseminated superficial actinic porokeratosis. Clin Exp Dermatol. 1990;15:370–371.
   Google Scholar
• Goldenberg G, Krowchuk DP, Jorizzo JL. Successful treatment of a therapy-resistant pyogenic granuloma with topical imiquimod 5% cream. J Dermatolog Treat. 2006;17:121–123.
   Web of Science ®Google Scholar
• Jensen JM, Egberts F, Proksch E, Hauschild A. Disseminated porokeratosis palmaris and plantaris treated with imiquimod cream to prevent malignancy. Acta Derm Venereol. 2005;85:550–551.
   Google Scholar
• Harrison S, Sinclair R. Porokeratosis of Mibelli: Successful treatment with topical 5% imiquimod cream. Australas J Dermatol. 2003;44:281–283.
   PubMedGoogle Scholar
• Agarwal S, Berth-Jones J. Porokeratosis of Mibelli: Successful treatment with 5% imiquimod cream. Br J Dermatol. 2002;146:338–339.
   PubMedGoogle Scholar
• Fitzpatrick TB, Wolff K. Fitzpatrick's dermatology in general medicine. 7th edition. New York: McGraw-Hill Medical; 2008.
   Google Scholar
• Spencer JM, Katz BE. Successful treatment of porokeratosis of Mibelli with diamond fraise dermabrasion. Arch Dermatol. 1992;128:1187–1188.
   Google Scholar
• Itoh M, Nakagawa H. Successful treatment of disseminated superficial actinic porokeratosis with Q-switched ruby laser. J Dermatol. 2007;34:816–820.
   PubMed Web of Science ®Google Scholar
• Lolis MS, Marmur ES. Treatment of disseminated superficial actinic porokeratosis (DSAP) with the Q-switched ruby laser. J Cosmet Laser Ther. 2008;10:124–127.
   PubMed Web of Science ®Google Scholar
• Liu HT. Treatment of lichen amyloidosis (LA) and disseminated superficial porokeratosis (DSP) with frequency-doubled Q-switched Nd:YAG laser. Dermatol Surg. 2000;26:958–962.
   PubMed Web of Science ®Google Scholar
• Manstein D, Herron GS, Sink RK, Tanner H, Anderson RR. Fractional photothermolysis: A new concept for cutaneous remodeling using microscopic patterns of thermal injury. Lasers Surg Med. 2004;34:426–438.
   PubMed Web of Science ®Google Scholar
• Geronemus RG. Fractional photothermolysis: Current and future applications. Lasers Surg Med. 2006;38:169–176.
   PubMed Web of Science ®Google Scholar
• Chrastil B, Glaich AS, Goldberg LH, Friedman PM. Fractional photothermolysis: A novel treatment for disseminated superficial actinic porokeratosis. Arch Dermatol. 2007;143:1450–1452.
   PubMedGoogle Scholar
• Ricci C, Rosset A, Panizzon RG. Bullous and pruritic variant of disseminated superficial actinic porokeratosis: Successful treatment with grenz rays. Dermatology. 1999;199:328–331.
   Google Scholar